We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
What's in Store for Science Applications (SAIC) Q2 Earnings?
Read MoreHide Full Article
Science Applications International Corporation (SAIC - Free Report) is set to report second-quarter fiscal 2020 earnings on Sep 5.
The company’s earnings surpassed the Zacks Consensus Estimate in each of the trailing four quarters, the average being 19.4%.
In the last reported quarter, the company delivered earnings of $1.36 per share, beating the Zacks Consensus Estimate of $1.21 and also improving 11% year over year.
Moreover, revenues surged 37% from the year-ago quarter to $1.62 billion and further outpaced the Zacks Consensus Estimate of $1.61 billion, driven by the acquisition of Engility.
For the fiscal second quarter, the Zacks Consensus Estimate for revenues is pegged at $1.64 billion, indicating a 47.1% improvement from the year-ago reported figure. For earnings, the consensus estimate stands at $1.27, suggesting a rise of 12.4% from the prior-year reported number.
Let’s see how things are shaping up prior to this announcement.
Factors to Consider
Science Applications’ second-quarter fiscal 2020 results are likely to benefit from its strong product portfolio, which is aiding contract wins. The company’s capability to sustain its existing contracts coupled with the newly-awarded ones across the customer portfolio is likely to be a steady tailwind.
Moreover, the integration of Engility buyout is expected to be a key driver this earnings season. In the last reported quarter, excluding Engility, revenues dipped 2.8% year over year.
The acquisition of Engility is also likely to boost the company’s margin profile and cash flow generation.
However, revenue dis-synergies due to the elimination of prime sub-duplicate revenues persist as a headwind. Further, higher interest expenses are an overhang on the bottom line.
Science Applications International Corporation Price and EPS Surprise
The proven Zacks model clearly shows that a company with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) has maximum chances of beating estimates if it also has a positive Earnings ESP. Zacks Rank #4 (Sell) or 5 (Strong Sell) stocks are best avoided. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Science Applications currently carries a Zacks Rank #3, which increases the predictive power of ESP. However, its Earnings ESP of 0.00% in the combination makes surprise prediction difficult.
Stocks to Consider
Here are some stocks worth considering as our model shows that these have the right combination of elements to beat on earnings in their upcoming releases:
EastGroup Properties, Inc. (EGP - Free Report) has an Earnings ESP of +0.35% and a Zacks Rank of 2.
Dril-Quip, Inc. (DRQ - Free Report) has an Earnings ESP of +36.79% and is Zacks #2 Ranked.
Legalizing THIS Could Be Even Bigger than Marijuana
Americans spend an estimated $150 billion in this industry every year… more than twice as much as they spend on marijuana.
Now that 8 states have fully-legalized it (with several more states following close behind), Zacks has identified 5 stocks that could soar in response to the powerful demand. One industry insider described the future as “mind-blowing” – and early investors can still get in ahead of the surge.
Image: Bigstock
What's in Store for Science Applications (SAIC) Q2 Earnings?
Science Applications International Corporation (SAIC - Free Report) is set to report second-quarter fiscal 2020 earnings on Sep 5.
The company’s earnings surpassed the Zacks Consensus Estimate in each of the trailing four quarters, the average being 19.4%.
In the last reported quarter, the company delivered earnings of $1.36 per share, beating the Zacks Consensus Estimate of $1.21 and also improving 11% year over year.
Moreover, revenues surged 37% from the year-ago quarter to $1.62 billion and further outpaced the Zacks Consensus Estimate of $1.61 billion, driven by the acquisition of Engility.
For the fiscal second quarter, the Zacks Consensus Estimate for revenues is pegged at $1.64 billion, indicating a 47.1% improvement from the year-ago reported figure. For earnings, the consensus estimate stands at $1.27, suggesting a rise of 12.4% from the prior-year reported number.
Let’s see how things are shaping up prior to this announcement.
Factors to Consider
Science Applications’ second-quarter fiscal 2020 results are likely to benefit from its strong product portfolio, which is aiding contract wins. The company’s capability to sustain its existing contracts coupled with the newly-awarded ones across the customer portfolio is likely to be a steady tailwind.
Moreover, the integration of Engility buyout is expected to be a key driver this earnings season. In the last reported quarter, excluding Engility, revenues dipped 2.8% year over year.
The acquisition of Engility is also likely to boost the company’s margin profile and cash flow generation.
However, revenue dis-synergies due to the elimination of prime sub-duplicate revenues persist as a headwind. Further, higher interest expenses are an overhang on the bottom line.
Science Applications International Corporation Price and EPS Surprise
Science Applications International Corporation price-eps-surprise | Science Applications International Corporation Quote
What Our Model Says
The proven Zacks model clearly shows that a company with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) has maximum chances of beating estimates if it also has a positive Earnings ESP. Zacks Rank #4 (Sell) or 5 (Strong Sell) stocks are best avoided. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Science Applications currently carries a Zacks Rank #3, which increases the predictive power of ESP. However, its Earnings ESP of 0.00% in the combination makes surprise prediction difficult.
Stocks to Consider
Here are some stocks worth considering as our model shows that these have the right combination of elements to beat on earnings in their upcoming releases:
General Mills, Inc. (GIS - Free Report) has an Earnings ESP of +0.37% and a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.
EastGroup Properties, Inc. (EGP - Free Report) has an Earnings ESP of +0.35% and a Zacks Rank of 2.
Dril-Quip, Inc. (DRQ - Free Report) has an Earnings ESP of +36.79% and is Zacks #2 Ranked.
Legalizing THIS Could Be Even Bigger than Marijuana
Americans spend an estimated $150 billion in this industry every year… more than twice as much as they spend on marijuana.
Now that 8 states have fully-legalized it (with several more states following close behind), Zacks has identified 5 stocks that could soar in response to the powerful demand. One industry insider described the future as “mind-blowing” – and early investors can still get in ahead of the surge.
See these 5 “sin stocks” now >>